SCHEMBL5963561

SCHEMBL5963561

CCNC1=C(c2ccccc2)S(=O)(=O)N(C)C12CCCCC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
SIGMAR1 Q99720 3/20 0.32
OPRM1 P35372 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
CYP2B6 P20813 1/20 0.31
PRCP P42785 1/20 0.31
GRIN1 Q05586 1/20 0.31
KCNH2 Q12809 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5963783 0.88 SLC6A4 (0.33) SLC6A2SLC6A4SLC6A3SIGMAR1OPRM1
SCHEMBL5963606 0.80 LMNA (0.32) SLC6A2SLC6A4SLC6A3SIGMAR1OPRM1
SCHEMBL5964017 0.78 GRIN1 (0.36) SLC6A2SLC6A4SLC6A3SIGMAR1OPRM1
SCHEMBL5963859 0.72 SLC6A2 (0.33) SLC6A2SLC6A4SLC6A3SIGMAR1OPRM1
SCHEMBL5963964 0.69 LMNA (0.31) SLC6A2SLC6A4SLC6A3OPRM1RXFP1
SCHEMBL6821055 0.68 RXFP1 (0.34) SIGMAR1OPRM1RXFP1LMNASMN1; SMN2
SCHEMBL5964213 0.68 HSD11B1 (0.33) SLC6A2SLC6A4SLC6A3LMNAHCN4
SCHEMBL6820669 0.67 OPRM1 (0.34) SIGMAR1OPRM1RXFP1LMNASMN1; SMN2
SCHEMBL6817272 0.67 OPRM1 (0.34) SIGMAR1OPRM1RXFP1LMNASMN1; SMN2
SCHEMBL5963662 0.65 ADORA2B (0.35) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125840-B2 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY (US) 2006-10-24 US disclosed
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues GHSR, GHRHR, SSTR4 SLC6A2 1380/4885SLC6A4 794/4885SLC6A3 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.